Ikuti
Sergey Shmakov
Sergey Shmakov
Email yang diverifikasi di nih.gov
Judul
Dikutip oleh
Dikutip oleh
Tahun
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
OO Abudayyeh, JS Gootenberg, S Konermann, J Joung, IM Slaymaker, ...
Science 353 (6299), aaf5573, 2016
24002016
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
KS Makarova, YI Wolf, J Iranzo, SA Shmakov, OS Alkhnbashi, SJJ Brouns, ...
Nature Reviews Microbiology 18 (2), 67-83, 2020
22022020
Discovery and functional characterization of diverse class 2 CRISPR-Cas systems
S Shmakov, OO Abudayyeh, KS Makarova, YI Wolf, JS Gootenberg, ...
Molecular cell 60 (3), 385-397, 2015
14852015
Diversity and evolution of class 2 CRISPR–Cas systems
S Shmakov, A Smargon, D Scott, D Cox, N Pyzocha, W Yan, ...
Nature reviews microbiology 15 (3), 169-182, 2017
11762017
Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28
AA Smargon, DBT Cox, NK Pyzocha, K Zheng, IM Slaymaker, ...
Molecular cell 65 (4), 618-630. e7, 2017
6402017
Recruitment of CRISPR-Cas systems by Tn7-like transposons
JE Peters, KS Makarova, S Shmakov, EV Koonin
Proceedings of the National Academy of Sciences 114 (35), E7358-E7366, 2017
2912017
CRISPR–Cas in mobile genetic elements: counter-defence and beyond
G Faure, SA Shmakov, WX Yan, DR Cheng, DA Scott, JE Peters, ...
Nature Reviews Microbiology 17 (8), 513-525, 2019
2732019
The CRISPR spacer space is dominated by sequences from species-specific mobilomes
SA Shmakov, V Sitnik, KS Makarova, YI Wolf, KV Severinov, EV Koonin
MBio 8 (5), 10.1128/mbio. 01397-17, 2017
2062017
Thousands of previously unknown phages discovered in whole-community human gut metagenomes
S Benler, N Yutin, D Antipov, M Rayko, S Shmakov, AB Gussow, ...
Microbiome 9, 1-17, 2021
1672021
Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis
SA Shmakov, KS Makarova, YI Wolf, KV Severinov, EV Koonin
Proceedings of the National Academy of Sciences 115 (23), E5307-E5316, 2018
1642018
Analysis of metagenome-assembled viral genomes from the human gut reveals diverse putative CrAss-like phages with unique genomic features
N Yutin, S Benler, SA Shmakov, YI Wolf, I Tolstoy, M Rayko, D Antipov, ...
Nature communications 12 (1), 1044, 2021
1202021
Toxin-antitoxin RNA pairs safeguard CRISPR-Cas systems
M Li, L Gong, F Cheng, H Yu, D Zhao, R Wang, T Wang, S Zhang, J Zhou, ...
Science 372 (6541), eabe5601, 2021
932021
Machine-learning approach expands the repertoire of anti-CRISPR protein families
AB Gussow, AE Park, AL Borges, SA Shmakov, KS Makarova, YI Wolf, ...
Nature communications 11 (1), 3784, 2020
882020
Pervasive generation of oppositely oriented spacers during CRISPR adaptation
S Shmakov, E Savitskaya, E Semenova, MD Logacheva, KA Datsenko, ...
Nucleic acids research 42 (9), 5907-5916, 2014
862014
Metagenomic analysis of bacterial communities of Antarctic surface snow
A Lopatina, S Medvedeva, S Shmakov, MD Logacheva, V Krylenkov, ...
Frontiers in Microbiology 7, 398, 2016
802016
Phylogenomics of Cas4 family nucleases
S Hudaiberdiev, S Shmakov, YI Wolf, MP Terns, KS Makarova, EV Koonin
BMC evolutionary biology 17, 1-14, 2017
762017
On the origin of reverse transcriptase-using CRISPR-Cas systems and their hyperdiverse, enigmatic spacer repertoires
S Silas, KS Makarova, S Shmakov, D Páez-Espino, G Mohr, Y Liu, ...
MBio 8 (4), 10.1128/mbio. 00897-17, 2017
702017
CRISPR enzymes and systems
K Severinov, F Zhang, YI Wolf, S Shmakov, E Semenova, L Minakhin, ...
US Patent 11,060,115, 2021
682021
CRISPRidentify: identification of CRISPR arrays using machine learning approach
A Mitrofanov, OS Alkhnbashi, SA Shmakov, KS Makarova, EV Koonin, ...
Nucleic acids research 49 (4), e20-e20, 2021
602021
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353: aaf5573
OO Abudayyeh, JS Gootenberg, S Konermann, J Joung, IM Slaymaker, ...
562016
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20